People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Pharma, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncology Analytics, Inc. | — | Pharma | Series B | $53.5M | $850.1M | 2016 |
| Aspire Health, Inc. | — | Healthtech | Series B | $49.9M | $776.9M | 2014 |
John Bradburn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Bradburn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Anderson | 1 | 11 |
| William Frist | 1 | 10 |
| Ann Lamont | 1 | 9 |
| Brad Smith | 1 | 6 |
| Thomas Hawes | 1 | 6 |
| WILLIAM H. FRIST | 1 | 6 |
| Marc Lippman | 1 | 5 |
| Matthew Downs | 1 | 5 |
| Robert Walton | 1 | 3 |
| Diane Seloff | 1 | 3 |
| Richard Bovender | 1 | 3 |
| Mike Tudeen | 1 | 2 |
| Byron H. Smith | 1 | 2 |
| Gene Fleming | 1 | 2 |
| Michael J. Liang | 1 | 2 |
| Ann J. Lamont | 1 | 2 |
| Nick Rosa | 1 | 2 |
| Mike H. Tudeen | 1 | 1 |
| Larry H. Kloess | 1 | 1 |
| Andrew Lasher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.